| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/02/2014 | CN103690733A Traditional Chinese medicine solution having function of preventing liver cancer and preparation method thereof |
| 04/02/2014 | CN103690726A Traditional Chinese medicinal solution having cancer prevention function and preparation method thereof |
| 04/02/2014 | CN103690707A Natural pharmaceutical composition |
| 04/02/2014 | CN103690706A Natural pharmaceutical composition as well as preparation method and use thereof |
| 04/02/2014 | CN103690681A Natural pharmaceutical composition |
| 04/02/2014 | CN103690680A Natural pharmaceutical composition |
| 04/02/2014 | CN103690665A Natural medicine composition |
| 04/02/2014 | CN103690647A Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse leukaemia cell L6565 proliferation |
| 04/02/2014 | CN103690646A Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lymphomata cell YAC-1 proliferation |
| 04/02/2014 | CN103690634A Natural pharmaceutical composition and preparation method thereof |
| 04/02/2014 | CN103690624A Natural pharmaceutical composition and preparation method thereof |
| 04/02/2014 | CN103690618A Pulsatilla chinensis total saponin oral emulsion and preparation method thereof |
| 04/02/2014 | CN103690609A Traditional Chinese medicine combination for whitening skin and removing freckles and preparing method of traditional Chinese medicine combination |
| 04/02/2014 | CN103690604A Natural pharmaceutical composition and preparation method thereof |
| 04/02/2014 | CN103690603A Traditional Chinese medicinal composition, as well as preparation method and application thereof |
| 04/02/2014 | CN103690601A Application and preparation method of heart strengthening tablets |
| 04/02/2014 | CN103690593A Compound preparation for treating primary liver cancer and preparation method |
| 04/02/2014 | CN103690585A Natural pharmaceutical composition as well as preparation method and application thereof |
| 04/02/2014 | CN103690584A Natural medicine composition as well as preparation method and application thereof |
| 04/02/2014 | CN103690579A Glaucescent fissistigma root soft capsule and preparation method thereof |
| 04/02/2014 | CN103690578A Grape seed oil soft capsule and preparation method thereof |
| 04/02/2014 | CN103690577A Method for ionic liquid aqueous two-phase extraction of flavones and saponins in songaria cynomorium herb |
| 04/02/2014 | CN103690569A Recombinant adeno-associated virus AAV-shCdc6 formulation as well as preparation and application thereof |
| 04/02/2014 | CN103690567A Gallnut ethyl acetate extract as well as preparation and detection methods and application thereof |
| 04/02/2014 | CN103690556A Hydroxycamptothecine long-circulating liposome |
| 04/02/2014 | CN103690550A Cancer-resistant use of compound separated from tea saponin |
| 04/02/2014 | CN103690549A Preparation of alpha-hederin solid dispersion and its cyclodextrin inclusion compound |
| 04/02/2014 | CN103690545A Oral prednisone time-selecting release preparation and preparation method thereof |
| 04/02/2014 | CN103690542A Inhibitors of poly(ADP-ribose)polymerase |
| 04/02/2014 | CN103690531A Application of ethyl coumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers |
| 04/02/2014 | CN103690530A Application of ethyl 6-chlorocoumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers |
| 04/02/2014 | CN103690529A Application of methyl coumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers |
| 04/02/2014 | CN103690528A Application of ethyl 6-bromocoumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers |
| 04/02/2014 | CN103690525A Application of Artoxanthochromane in preparation of medicine for treating tongue cancer |
| 04/02/2014 | CN103690519A Application of salvianolic acid A in preparation of medicine for treating tumour multi-drug resistance |
| 04/02/2014 | CN103690512A Deoxidized podophyllotoxin polymer micelle freeze-drying preparation |
| 04/02/2014 | CN103690511A Method for preparing Ftorafur-loaded vesicle |
| 04/02/2014 | CN103690494A Low-impurity composition containing oxaliplatin and preparation method thereof |
| 04/02/2014 | CN103690492A Preparation method of lipoic acid particles |
| 04/02/2014 | CN103690487A Carrier-free micro-nano resveratrol medicament and preparation and application thereof |
| 04/02/2014 | CN103690486A Indocyanine green nanometer targeted liposome as well as preparation method and application thereof |
| 04/02/2014 | CN103689171A Healthcare tea capable of tonifying qi, tonifying spleen and tonifying kidney |
| 04/02/2014 | CN103006609B Anastrozole tablet composition and preparation method thereof |
| 04/02/2014 | CN102940890B Gene application in inhibition and apoptosis of glioma cell |
| 04/02/2014 | CN102911157B (E)-3-[2-bromo-5-(3-substituted propoxy)]phenyl-N-{4-methyl-3-[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl acrylamide compound |
| 04/02/2014 | CN102898489B Rebeccamycin analogue with anticancer activity and synthetic method thereof |
| 04/02/2014 | CN102885786B Mixed micelle freeze-dried preparation loaded with docetaxel and preparation method thereof |
| 04/02/2014 | CN102861308B Chinese medicinal preparation for treating esophageal carcinoma and preparation method thereof |
| 04/02/2014 | CN102861062B Application of Houttuynoid C in endometrial cancer treatment medicine |
| 04/02/2014 | CN102846553B Preparation method for chlorella polypeptide-chitosan nanoparticle |
| 04/02/2014 | CN102836436B Integrin receptor-targeted taxol nanocomposite and preparation method thereof |
| 04/02/2014 | CN102836430B Application of blocking antibody T5E3 to reversing of tumor multidrug resistance |
| 04/02/2014 | CN102827272B Folate coupling antibody drug and preparation method and use thereof |
| 04/02/2014 | CN102793666B Liposome for anthocyanin extract and preparation method for liposome |
| 04/02/2014 | CN102755627B Method for preparing goserelin slow-release implant |
| 04/02/2014 | CN102755359B Hippophae extract and preparation method and application thereof for inhibiting activity of fatty acid synthase |
| 04/02/2014 | CN102747083B Application of splicing factor oncoprotein SF2/ASF in preparation of medicines used for treating leukemia |
| 04/02/2014 | CN102746418B Sansevieria trifasciata polysaccharides as well as preparation method and application thereof |
| 04/02/2014 | CN102740850B Pyridyl cyanoguanidine derivatives |
| 04/02/2014 | CN102703456B Action target site of death-associated protein kinase (DAPK3) gene hsa-miR-20a |
| 04/02/2014 | CN102702454B PH response four-arm star block copolymer and preparation method and application thereof |
| 04/02/2014 | CN102671079B Medicine for treating liver cancer |
| 04/02/2014 | CN102665727B Anti-cancer agent |
| 04/02/2014 | CN102659803B Sesterterpene compound and preparation method and application thereof |
| 04/02/2014 | CN102643858B Efficiently-replicated human hepatitis B virus recombinant vector and application thereof |
| 04/02/2014 | CN102626469B Method for preparing high-purity tea polyphenol in centrifuging, extracting and separating mode |
| 04/02/2014 | CN102614162B Application of gingerol and cerous oxalate composition to preparation of toxicity-decreasing and efficacy-increasing drugs for cancer chemotherapy |
| 04/02/2014 | CN102600164B Application of pyrimidine ether compounds in preparing anti-tumor medicines |
| 04/02/2014 | CN102552301B Medicine composition and application thereof |
| 04/02/2014 | CN102552105B Cascade brain-targeting drug delivery system as well as preparation method and application thereof |
| 04/02/2014 | CN102525928B Cis-platinum long-cycle liposome and preparation method thereof |
| 04/02/2014 | CN102516338B Capecitabine compound, pharmaceutical composition and preparation method thereof |
| 04/02/2014 | CN102471264B 5,5-disubstituted-2-imino-pyrrolidine derivatives, preparation methods and pharmaceutical uses thereof |
| 04/02/2014 | CN102462691B Medicine composition for treating tumor and preparation method thereof |
| 04/02/2014 | CN102408395B Novel piperazine and homopiperazine derivative and preparation method and use thereof |
| 04/02/2014 | CN102274186B Mirror image polypeptide lipid nanometer preparation used for anticancer |
| 04/02/2014 | CN102227218B Tnik inhibitor and use thereof |
| 04/02/2014 | CN102167690B Icariin aglucone derivative and preparation method and application thereof |
| 04/02/2014 | CN102153517B Diaryl pyrimidone hydrazone derivatives and preparation method and application of diaryl pyrimidone hydrazone derivatives |
| 04/02/2014 | CN102143750B Macrocyclics pyrimidines as aurora kinase inhibitors |
| 04/02/2014 | CN102050878B Anti-human CD20 humanized antibody and preparation method and application thereof |
| 04/02/2014 | CN102031254B Human miR-150 antisense nucleic acid and application thereof |
| 04/02/2014 | CN102014900B Method of treating cancer using a neuropeptide Y5R (NPY5R) antagonist |
| 04/02/2014 | CN101991532B Self-microemulsion composition, microemulsion and preparation methods thereof |
| 04/02/2014 | CN101981029B Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 04/02/2014 | CN101939314B Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 04/02/2014 | CN101875694B Antibody of TNF (Tumor Necrosis Factor) alpha and application thereof |
| 04/02/2014 | CN101659658B Quinoline substituted by cyan |
| 04/02/2014 | CN101631463B Cyclopamine analogs |
| 04/01/2014 | US8686155 Aurora kinase modulators and method of use |
| 04/01/2014 | US8686143 Compounds useful as inhibitors of Janus kinases |
| 04/01/2014 | US8686128 Agent for targeting c-Jun mRNA |
| 04/01/2014 | US8686120 DRG11-responsive (DRAGON) gene family |
| 04/01/2014 | US8686021 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin E2 (PGE2) |
| 04/01/2014 | US8685980 Pyrrolopyrimidine compounds and their uses |
| 04/01/2014 | US8685971 Quinolinyloxyphenylsulfonamides |
| 04/01/2014 | US8685931 Hair growth methods using FGFR3 extracellular domains |
| 04/01/2014 | US8685929 Detecting CYP24 expression level as a marker for predisposition to cancer |
| 04/01/2014 | US8685928 Antagonists of MUC1 |
| 04/01/2014 | US8685734 Viral purification methods |